Open Beta
MetriLume

US marketsBTMD

SEC-sourced researchBeta

BTMD

biote Corp.

Company comparison ↗

Data passport

CIK
0001819253
Exchange
Nasdaq
Business activity
Medicinal Chemicals & Botanical Products · SIC 2833
Financial inputs
6/6
Filing date
Nov 12, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 197,191,000.0000 USD; December 2025: 192,219,000.0000 USD197.2M USD0 USD0December 2024December 2025
BTMD · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024197,191,000.0000Mar 13, 2026
December 2025192,219,000.0000Mar 13, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025192,219,000.000027,045,000.000035,194,000.0000107,613,000.0000158,010,000.0000Mar 13, 2026
December 2024197,191,000.00003,157,000.000045,243,000.0000122,370,000.0000224,570,000.0000Mar 13, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

62/100
Profitability78
Growth47
Balance sheet0
Cash generation87
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$192.22MJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$197.19MJan 1, 2024 – Dec 31, 2024Mar 13, 202610-K
Net incomeNetIncomeLoss$27.05MJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$35.19MJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Total assetsAssets$107.61MDec 31, 2025Mar 13, 202610-K
Total liabilitiesLiabilities$158.01MDec 31, 2025Mar 13, 202610-K

New filings

Explore methodology ↗